News

Our medical news may contain information about Shionogi products and is therefore intended for medical journalists and health care professionals only. By clicking through to see medical news, you are confirming that you are a medical journalist or healthcare professional.

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

April

17 Apr 2023 Release Medical News
ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja® (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens
05 Apr 2023 Release Medical News
Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19
05 Apr 2023 Release Medical News
ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment Additional Data to be Presented Showing Significantly Faster Time to Negative Viral Titer (Culture) Compared to Placebo

February

23 Feb 2023 Release Medical News
Shionogi’s antibiotic, Fetcroja® (cefiderocol), is now available in the Netherlands
22 Feb 2023 Release Medical News
Shionogi Presents Pivotal Ensitrelvir Fumaric Acid Phase 3 Data and Exploratory Long COVID Data at CROI
15 Feb 2023 Release Medical News
Shionogi Advances Ensitrelvir Fumaric Acid COVID-19 Antiviral Clinical Program

Select Year

NP-EU-NP-0180 | August 2022